Online security

CDC Approves Updated ACIP COVID-19 Vaccine Recommendations | CDC Online Newsroom


Today, the CDC approves the updated recommendations made by the Advisory Committee on Immunization Practices (ACIP) for the prevention of COVID-19, expressing a clinical preference for individuals to receive a COVID-19 mRNA vaccine by report to Johnson & Johnson’s COVID-19 vaccine. ACIP’s unanimous recommendation follows an extensive discussion of the latest evidence on vaccine efficacy, vaccine safety and rare adverse events, and consideration of the vaccine supply in the United States. The US supply of mRNA vaccines is plentiful – with nearly 100 million doses in the field for immediate use. This updated CDC recommendation follows similar recommendations from other countries, including Canada and the United Kingdom. Given the current state of the pandemic here and around the world, ACIP has reaffirmed that it is better to receive any vaccine than not to be vaccinated. People who cannot or do not want to receive an mRNA vaccine will continue to have access to the COVID-19 vaccine from Johnson & Johnson.

The following is attributable to CDC Director Dr. Rochelle Walensky

“We have made significant progress during the year since the start of the COVID-19 vaccination program. More than 200 million Americans have completed their primary vaccine series, providing protection against COVID-19, preventing millions of cases and hospitalizations, and saving more than a million lives. Today’s updated recommendation underscores the CDC’s commitment to providing real-time scientific information to the American public. I continue to encourage all Americans to get vaccinated and boosted.